267 related articles for article (PubMed ID: 26755727)
21. NAA10 as a New Prognostic Marker for Cancer Progression.
Kim SM; Ha E; Kim J; Cho C; Shin SJ; Seo JH
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126484
[TBL] [Abstract][Full Text] [Related]
22. Charting the N-Terminal Acetylome: A Comprehensive Map of Human NatA Substrates.
Van Damme P
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639033
[TBL] [Abstract][Full Text] [Related]
23. Naa10p Inhibits Beige Adipocyte-Mediated Thermogenesis through N-α-acetylation of Pgc1α.
Lee CC; Shih YC; Kang ML; Chang YC; Chuang LM; Devaraj R; Juan LJ
Mol Cell; 2019 Nov; 76(3):500-515.e8. PubMed ID: 31422874
[TBL] [Abstract][Full Text] [Related]
24. ARD1/NAA10 acetylation in prostate cancer.
Kuhns KJ; Zhang G; Wang Z; Liu W
Exp Mol Med; 2018 Jul; 50(7):1-8. PubMed ID: 30054487
[TBL] [Abstract][Full Text] [Related]
25. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
[TBL] [Abstract][Full Text] [Related]
26. A novel human NatA Nalpha-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1).
Arnesen T; Gromyko D; Kagabo D; Betts MJ; Starheim KK; Varhaug JE; Anderson D; Lillehaug JR
BMC Biochem; 2009 May; 10():15. PubMed ID: 19480662
[TBL] [Abstract][Full Text] [Related]
27. Implications for the evolution of eukaryotic amino-terminal acetyltransferase (NAT) enzymes from the structure of an archaeal ortholog.
Liszczak G; Marmorstein R
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14652-7. PubMed ID: 23959863
[TBL] [Abstract][Full Text] [Related]
28. A novel NAA10 variant with impaired acetyltransferase activity causes developmental delay, intellectual disability, and hypertrophic cardiomyopathy.
Støve SI; Blenski M; Stray-Pedersen A; Wierenga KJ; Jhangiani SN; Akdemir ZC; Crawford D; McTiernan N; Myklebust LM; Purcarin G; McNall-Knapp R; Wadley A; Belmont JW; Kim JJ; Lupski JR; Arnesen T
Eur J Hum Genet; 2018 Sep; 26(9):1294-1305. PubMed ID: 29748569
[TBL] [Abstract][Full Text] [Related]
29. Expanding the phenotypic spectrum of NAA10-related neurodevelopmental syndrome and NAA15-related neurodevelopmental syndrome.
Lyon GJ; Vedaie M; Beisheim T; Park A; Marchi E; Gottlieb L; Hsieh TC; Klinkhammer H; Sandomirsky K; Cheng H; Starr LJ; Preddy I; Tseng M; Li Q; Hu Y; Wang K; Carvalho A; Martinez F; Caro-Llopis A; Gavin M; Amble K; Krawitz P; Marmorstein R; Herr-Israel E
Eur J Hum Genet; 2023 Jul; 31(7):824-833. PubMed ID: 37130971
[TBL] [Abstract][Full Text] [Related]
30. NAA10 dysfunction with normal NatA-complex activity in a girl with non-syndromic ID and a de novo NAA10 p.(V111G) variant - a case report.
McTiernan N; Støve SI; Aukrust I; Mårli MT; Myklebust LM; Houge G; Arnesen T
BMC Med Genet; 2018 Mar; 19(1):47. PubMed ID: 29558889
[TBL] [Abstract][Full Text] [Related]
31. Proteome-derived peptide libraries allow detailed analysis of the substrate specificities of N(alpha)-acetyltransferases and point to hNaa10p as the post-translational actin N(alpha)-acetyltransferase.
Van Damme P; Evjenth R; Foyn H; Demeyer K; De Bock PJ; Lillehaug JR; Vandekerckhove J; Arnesen T; Gevaert K
Mol Cell Proteomics; 2011 May; 10(5):M110.004580. PubMed ID: 21383206
[TBL] [Abstract][Full Text] [Related]
32. Diverse roles of arrest defective 1 in cancer development.
Chaudhary P; Ha E; Vo TTL; Seo JH
Arch Pharm Res; 2019 Dec; 42(12):1040-1051. PubMed ID: 31813105
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of the human ARD1-NATH protein acetyltransferase complex.
Arnesen T; Anderson D; Baldersheim C; Lanotte M; Varhaug JE; Lillehaug JR
Biochem J; 2005 Mar; 386(Pt 3):433-43. PubMed ID: 15496142
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15.
Cheng H; Gottlieb L; Marchi E; Kleyner R; Bhardwaj P; Rope AF; Rosenheck S; Moutton S; Philippe C; Eyaid W; Alkuraya FS; Toribio J; Mena R; Prada CE; Stessman H; Bernier R; Wermuth M; Kauffmann B; Blaumeiser B; Kooy RF; Baralle D; Mancini GMS; Conway SJ; Xia F; Chen Z; Meng L; Mihajlovic L; Marmorstein R; Lyon GJ
Hum Mol Genet; 2019 Sep; 28(17):2900-2919. PubMed ID: 31127942
[TBL] [Abstract][Full Text] [Related]
35. Structural basis of HypK regulating N-terminal acetylation by the NatA complex.
Weyer FA; Gumiero A; Lapouge K; Bange G; Kopp J; Sinning I
Nat Commun; 2017 Jun; 8():15726. PubMed ID: 28585574
[TBL] [Abstract][Full Text] [Related]
36. Protein N-terminal Acetylation by the NatA Complex Is Critical for Selective Mitochondrial Degradation.
Eiyama A; Okamoto K
J Biol Chem; 2015 Oct; 290(41):25034-44. PubMed ID: 26296886
[TBL] [Abstract][Full Text] [Related]
37. Biochemical analysis of novel NAA10 variants suggests distinct pathogenic mechanisms involving impaired protein N-terminal acetylation.
McTiernan N; Tranebjærg L; Bjørheim AS; Hogue JS; Wilson WG; Schmidt B; Boerrigter MM; Nybo ML; Smeland MF; Tümer Z; Arnesen T
Hum Genet; 2022 Aug; 141(8):1355-1369. PubMed ID: 35039925
[TBL] [Abstract][Full Text] [Related]
38. N-α-acetyltransferase 10 protein promotes metastasis by stabilizing matrix metalloproteinase-2 protein in human osteosarcomas.
Chien MH; Lee WJ; Yang YC; Tan P; Pan KF; Liu YC; Tsai HC; Hsu CH; Wen YC; Hsiao M; Hua KT
Cancer Lett; 2018 Oct; 433():86-98. PubMed ID: 29960050
[TBL] [Abstract][Full Text] [Related]
39. N-terminal acetylome analysis reveals the specificity of Naa50 (Nat5) and suggests a kinetic competition between N-terminal acetyltransferases and methionine aminopeptidases.
Van Damme P; Hole K; Gevaert K; Arnesen T
Proteomics; 2015 Jul; 15(14):2436-46. PubMed ID: 25886145
[TBL] [Abstract][Full Text] [Related]
40. Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-1alpha fragments in vitro.
Murray-Rust TA; Oldham NJ; Hewitson KS; Schofield CJ
FEBS Lett; 2006 Apr; 580(8):1911-8. PubMed ID: 16500650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
